Nicoccino Holding AB (publ) (STO:NICO)
0.8750
+0.0300 (3.55%)
Jun 4, 2026, 5:30 PM CET
Nicoccino Holding AB Revenue
Nicoccino Holding AB had revenue of 287.00K SEK in the quarter ending March 31, 2026, with 114.18% growth. This brings the company's revenue in the last twelve months to 1.04M, up 134.99% year-over-year. In the year 2025, Nicoccino Holding AB had annual revenue of 889.00K with 125.63% growth.
Revenue (ttm)
1.04M
Revenue Growth
+134.99%
P/S Ratio
25.04
Revenue / Employee
520.50K
Employees
2
Market Cap
26.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 889.00K | 495.00K | 125.63% |
| Dec 31, 2024 | 394.00K | 231.00K | 141.72% |
| Dec 31, 2023 | 163.00K | 13.00K | 8.67% |
| Dec 31, 2022 | 150.00K | 94.00K | 167.86% |
| Dec 31, 2021 | 56.00K | 2.00K | 3.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Essity AB | 136.70B |
| Axfood AB | 89.71B |
| AAK AB (publ.) | 45.67B |
| Cloetta AB | 8.60B |
| New Nordic Healthbrands AB | 565.03M |
| Tellusgruppen AB | 495.58M |
| Clemondo Group AB | 295.48M |
| Lohilo Foods AB | 198.07M |
Nicoccino Holding AB News
- 7 days ago - Nicoccino Holding AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Nicoccino Holding AB Quarterly report: Q4 2025 - Filings
- 3 months ago - Nicoccino Holding AB Annual report: Q4 2025 - Filings
- 6 months ago - Nicoccino Holding AB Quarterly report: Q3 2025 - Filings
- 10 months ago - Nicoccino Holding AB Quarterly report: Q2 2025 - Filings